Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Free fatty acids
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.108
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Free fatty acids
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.522
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.203
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.884
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Calcium
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.000843
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Calcium
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0789
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Total cholesterol
|
HOM
|
5f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.0337
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Total cholesterol
|
HET
|
5f:2m
|
Linear Mixed Model framework, LME, including Weight
|
0.0751
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Total cholesterol
|
HET
|
4f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.210
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Total cholesterol
|
HOM
|
3f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.980
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Glucose
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.458
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Glucose
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.570
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Triglycerides
|
HET
|
5f:2m
|
Linear Mixed Model framework, LME, including Weight
|
0.191
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Triglycerides
|
HOM
|
3f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.280
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Triglycerides
|
HOM
|
5f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.757
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Triglycerides
|
HET
|
4f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.933
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Sodium
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.000110
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Sodium
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.651
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
1.33×10-16
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0811
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Iron
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.000826
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Iron
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.223
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00493
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HET
|
9f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.853
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Total cholesterol
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
3.14×10-06
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Total cholesterol
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.414
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Total protein
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.319
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Total protein
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.901
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Cholesterol ratio
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0542
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Cholesterol ratio
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0810
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / HDL cholesterol
|
HOM
|
5f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.00184
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / HDL cholesterol
|
HET
|
5f:2m
|
Linear Mixed Model framework, LME, including Weight
|
0.0478
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / HDL cholesterol
|
HET
|
4f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.178
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / HDL cholesterol
|
HOM
|
3f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.200
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00237
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HET
|
9f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00405
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Albumin
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.338
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Albumin
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.576
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Potassium
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.000127
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Potassium
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.157
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Body Composition (DEXA lean/fat) / Fat mass
|
HET
|
9f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.00313
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Body Composition (DEXA lean/fat) / Fat mass
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0857
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HET
|
9f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.600
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.706
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Phosphorus
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
4.64×10-05
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Phosphorus
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.999
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
4.08×10-10
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / HDL-cholesterol
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.150
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Insulin Blood Level / Insulin
|
HET
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00850
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Insulin Blood Level / Insulin
|
HOM
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.413
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Chloride
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.174
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Chloride
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.516
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Free fatty acids
|
HOM
|
3f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0310
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Free fatty acids
|
HET
|
4f:4m
|
Linear Mixed Model framework, LME, including Weight
|
2.22×10-06
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Free fatty acids
|
HOM
|
5f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.824
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Free fatty acids
|
HET
|
5f:2m
|
Linear Mixed Model framework, LME, not including Weight
|
0.920
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HOM
|
35f:40m
|
|
|
NotProcessed |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HET
|
45f:40m
|
|
|
NotProcessed |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HET
|
9f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.100
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.155
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Total bilirubin
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.383
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Total bilirubin
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.395
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.00139
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0405
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Glucose
|
HOM
|
5f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.0117
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Glucose
|
HOM
|
3f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0134
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Glucose
|
HET
|
5f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.529
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Glucose
|
HET
|
4f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.927
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Triglycerides
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.327
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Triglycerides
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.578
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.111
|
Successful |
Arrb2tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.321
|
Successful |